Latest China News

Netlinkz Limited reported $979,000 in quarterly receipts and a landmark $1 million VSN license sale in the Philippines, while advancing significant cost reductions and debt restructuring efforts.

Viridis Mining and Minerals has raised AU$11.5 million through a heavily oversubscribed placement, strengthening its balance sheet to advance the Colossus Rare Earth Project towards Final Investment Decision. The funding, backed by institutional and strategic Brazilian partners, positions Viridis with nearly AU$58.5 million in cash to accelerate development and regulatory approvals.

NGX Limited progresses its Malingunde graphite project with technical studies and stakeholder engagement, while uranium exploration permits advance in Namibia. The company stands to benefit from new US anti-dumping tariffs on Chinese graphite imports.

Firebird Metals is developing Lithium Manganese Rich cathode materials to target next-generation solid-state batteries, aiming to strengthen its position in the evolving EV and high-energy battery markets.

Ionic Rare Earths’ Belfast plant is ramping up production of critical heavy rare earth oxides to meet soaring demand from Western markets following China’s export restrictions. This strategic move positions the company as a key supplier for defence, renewables, and advanced manufacturing sectors.

Felix Gold is advancing its Treasure Creek Project in Alaska, aiming for the first domestic antimony concentrate production in over 30 years by late 2025 or early 2026, supported by strong government engagement and solid finances.

Locksley Resources has advanced its Mojave Project with critical drilling permits secured, a strategic $1.47 million capital raise, and a new U.S. OTCQB listing, setting the stage for maiden drilling campaigns targeting rare earths and antimony.

Appen Limited reported a mixed Q2 FY25 with a 6% revenue decline year-over-year, driven by a strong 77% surge in its China business that achieved profitability, while US market challenges persist. The company targets $10 million in cost savings to fuel future growth.

Noxopharm has initiated its HERACLES clinical trial for SOF-SKN, marking a key milestone for its Sofra platform, while deepening partnerships and actively seeking new funding to sustain development.

Pilbara Minerals delivered robust FY25 results, completing key expansions and beating production guidance, while setting a cost-focused FY26 plan amid ongoing lithium price volatility.

Industrial Minerals Ltd reports significant progress on its Pippingarra Project, advancing strategic partnerships across the Asia-Pacific and validating high purity quartz, feldspar, and mica products through positive testwork results.

Merino & Co reported a robust quarter highlighted by the successful launch of its Merino possum range, strategic international hires, and a solid cash position of $3.02 million, positioning the company for sustained expansion.